Venture Life Group has announced the acquisition of Health & Her (H&H) for an upfront cash consideration of £7.5 million, with additional payments of up to £2.5 million tied to performance and retention milestones. The acquisition strengthens Venture Life’s position in the rapidly growing hormone health market.
Founded in 2018 and headquartered in Cardiff (UK), H&H has established itself as a leading brand in hormonal wellbeing supplements. Its digital presence is particularly notable, with its menopause app ranking as the world’s second-largest according to the company and receiving top recommendations from ORCHA. H&H reported revenues of £6.1 million for the financial year ended May 2024.
The acquisition comes at a significant time for the menopause market, which was valued at $16 billion in 2023 and is projected to reach $600 billion by 2030, according to Forbes Magazine estimates.
“We are delighted to have acquired H&H, an exciting and dynamic business in the innovative area of supporting hormone change in men and women through all life stages. The business has been well invested in its growth and development, and we will be able to leverage all these assets going forward. Recent new launches into the US retail market and a deep pipeline of new products are expected to deliver meaningful growth in the short to medium term,” said Jerry Randall, CEO of Venture Life Group.
H&H’s founders, Kate Bache and Gervase Fay, will remain with the business. “We are thrilled by today’s announcement of the acquisition of H&H by VLG. Venture Life Group’s success and momentum in the self-care space, combined with their extensive retail and market reach, promise to further our mission to support the lives of millions of people around the world with the life-affecting impact of hormone change. Joining VLG opens up extensive opportunities for synergies – particularly within the female health category alongside the VLG brand Balance Activ. We’re confident that our combined strengths will bring significant value to our customers and key stakeholders as we embark on this exciting new chapter,” they commented.
The company currently sells through major retailers including Holland & Barrett, Boots, and Superdrug in the UK, and has recently secured listings with CVS and The Vitamin Shoppe in the USA.
